Expression/NN
of/IN
transcription/NN
factors/NNS
during/IN
sodium/NN
phenylacetate/NN
induced/VBD
erythroid/JJ
differentiation/NN
in/IN
K562/NN
cells/NNS
./.

During/IN
15/CD
days/NNS
of/IN
treatment/NN
of/IN
K562/NN
cells/NNS
with/IN
sodium/NN
phenylacetate/NN
,/,
we/PRP
observed/VBD
an/DT
increase/NN
in/IN
the/DT
cellular/JJ
hemoglobin/NN
concentration/NN
with/IN
a/DT
similar/JJ
increase/NN
in/IN
the/DT
expression/NN
of/IN
gamma-globin/NN
mRNA/NN
./.
=====
Morphological/JJ
studies/NNS
demonstrated/VBD
characteristic/JJ
features/NNS
of/IN
erythroid/JJ
differentiation/NN
and/CC
maturation/NN
./.
=====
At/IN
the/DT
same/JJ
time/NN
there/EX
was/VBD
no/DT
change/NN
in/IN
the/DT
level/NN
of/IN
expression/NN
of/IN
the/DT
cell/NN
surface/NN
antigenes/NNS
CD33/NN
,/,
CD34/NN
,/,
CD45/NN
,/,
CD71/NN
and/CC
glycophorin/NN
A/NN
./.
=====
Likewise/RB
,/,
the/DT
level/NN
of/IN
expression/NN
of/IN
the/DT
erythroid/JJ
transcription/NN
factors/NNS
GATA-1/NN
,/,
GATA-2/NN
,/,
NF-E2/NN
,/,
SCL/NN
and/CC
RBTN2/NN
,/,
all/DT
expressed/VBN
in/IN
untreated/JJ
K562/NN
cells/NNS
,/,
did/VBD
not/RB
increase/VB
during/IN
sodium/NN
phenylacetate/NN
induced/JJ
erythroid/JJ
differentiation/NN
./.
=====
The/DT
expression/NN
of/IN
the/DT
nuclear/JJ
factors/NNS
Evi-1/NN
and/CC
c-myb/NN
,/,
known/VBN
to/TO
inhibit/VB
erythroid/JJ
differentiation/NN
,/,
did/VBD
not/RB
decrease/VB
./.
=====
We/PRP
conclude/VBP
that/IN
sodium/NN
phenylacetate/NN
treatment/NN
of/IN
K562/NN
cells/NNS
increases/VBZ
gamma-globin/NN
mRNA/NN
and/CC
induces/VBZ
cell/NN
maturation/NN
as/IN
judged/VBN
by/IN
morphology/NN
without/IN
affecting/VBG
the/DT
expression/NN
of/IN
the/DT
erythroid/JJ
transcription/NN
factors/NNS
,/,
some/DT
of/IN
which/WDT
are/VBP
known/VBN
to/TO
be/VB
involved/VBN
in/IN
the/DT
regulation/NN
of/IN
beta-like/JJ
globin/NN
genes/NNS
./.